Literature DB >> 2345955

Binding characteristics of ivermectin in plasma from collie dogs.

S P Rohrer1, D V Evans.   

Abstract

Two types of experiments were performed in an effort to demonstrate a role for plasma proteins in determining the amount of ivermectin available for transport across the blood-brain barrier of collie dogs sensitive to the effects of the compound. The solubility of ivermectin in plasma from non-sensitive and sensitive collies was measured and found to be identical at 100 micrograms/ml. An assay for measuring the low affinity binding interaction of ivermectin with plasma components was developed. The amount of ivermectin bound per unit of plasma was the same for samples from sensitive and non-sensitive dogs. Dog serum albumin and the high density lipoprotein portion of the plasma were both capable of binding ivermectin. No differences in the binding characteristics of ivermectin in plasma from ivermectin sensitive and non-sensitive collies were found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345955     DOI: 10.1007/bf00346556

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  10 in total

1.  Ivermectin: an update.

Authors:  W C Campbell
Journal:  Parasitol Today       Date:  1985-07

2.  Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis.

Authors:  W J Tranquilli; A J Paul; R L Seward
Journal:  Am J Vet Res       Date:  1989-05       Impact factor: 1.156

3.  Milbemycin D concentrations in tissues after oral administration in collies, shelties and Japanese mongrel dogs.

Authors:  Y Sasaki; H Kitagawa; K Ishihara; K Ishizako
Journal:  Nihon Juigaku Zasshi       Date:  1988-12

4.  Plasma milbemycin D concentrations in collies, shelties and Japanese mongrel dogs.

Authors:  H Kitagawa; Y Sasaki; K Ishihara; K Ishizako
Journal:  Nihon Juigaku Zasshi       Date:  1988-12

5.  Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis.

Authors:  W J Tranquilli; A J Paul; R L Seward; K S Todd; J A Dipietro
Journal:  J Vet Pharmacol Ther       Date:  1987-03       Impact factor: 1.786

6.  Pharmacokinetic studies of ivermectin: effects of formulation.

Authors:  P K Lo; D W Fink; J B Williams; J Blodinger
Journal:  Vet Res Commun       Date:  1985-09       Impact factor: 2.459

Review 7.  Comparative analysis of mammalian plasma lipoproteins.

Authors:  M J Chapman
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

8.  Ivermectin in the dog.

Authors:  S M Easby
Journal:  Vet Rec       Date:  1984-07-14       Impact factor: 2.695

9.  Ivermectin toxicosis in a dog.

Authors:  D M Houston; J Parent; K J Matushek
Journal:  J Am Vet Med Assoc       Date:  1987-07-01       Impact factor: 1.936

10.  Clinical observations in collies given ivermectin orally.

Authors:  A J Paul; W J Tranquilli; R L Seward; K S Todd; J A DiPietro
Journal:  Am J Vet Res       Date:  1987-04       Impact factor: 1.156

  10 in total
  3 in total

1.  The effect of protein binding on ivermectin uptake by bovine brain microvessel endothelial cells.

Authors:  K L Audus; S R Knaub; F L Guillot; J M Schaeffer
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  Patterns of doramectin tissue residue depletion in parasitized vs nonparasitized lambs.

Authors:  Rubén Pérez; Cristina Palma; Maria José Nuñez; Ignacio Cabezas
Journal:  Parasitol Res       Date:  2008-01-16       Impact factor: 2.289

Review 3.  A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.

Authors:  David E Scheim
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.